Table 2.
Characteristic | Nonfrail (n = 828) | Frail (n = 790) |
---|---|---|
Age, n (%) | ||
Median (range), years | 70 (40–80) | 77 (44–92) |
<65 years | 66 (8) | 26 (3) |
65–75 years | 754 (91) | 299 (38) |
76–80 years | 74 (9) | 290 (37) |
>80 years | 0 | 201 (25) |
Sex, n (%) | ||
Male | 436 (53) | 415 (53) |
Female | 392 (47) | 375 (47) |
ECOG performance status, n (%)a | ||
0 | 401 (48) | 73 (9) |
1 | 427 (52) | 368 (47) |
2 | 0 | 343 (43) |
3 | 0 | 6 (<1) |
Data not available | 0 | 0 |
International Staging System stage, n (%)b | ||
I or II | 575 (69) | 419 (53) |
III | 253 (31) | 371 (47) |
Lactate dehydrogenase, n (%) | ||
<200 U/L | 707 (85) | 612 (78) |
≥200 U/L | 120 (15) | 177 (22) |
Missing data | 1 | 1 |
Creatinine clearance, n (%) | ||
<60 mL/min | 299 (36) | 478 (61) |
<30 mL/min | 38 (5) | 108 (14) |
≥60 mL/min | 529 (64) | 312 (39) |
ECOG Eastern Cooperative Oncology Group
aECOG scores range from 0 to 5, with higher numbers indicating greater disability
bHigher stages indicate more severe disease